A multiple correspondence analysis was carried out in order to suggest clinical and genetic associations between the methylation status of ITGA1, ITGA4, ITGA9, NID1, and NID2 and clinical/morphological characteristics of the tumors, including the disease stage, tumor grade, tumor type, as well as estrogen receptor, progesterone receptor, and HER2 expression assessed by immunohistochemistry (IHC). This evidence concerns the gene ERBB2 and neoplasm.